Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
93.1M
-
Number of holders
-
54
-
Total shares
-
20.7M
-
Shares change
-
+3.15M
-
Total reported value, excl. options
-
$304M
-
Value change
-
+$45.4M
-
Number of buys
-
19
-
Number of sells
-
-27
-
Price
-
$14.70
Significant Holders of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) as of Q1 2020
53 filings reported holding CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock as of Q1 2020.
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.7M shares
of 93.1M outstanding shares and own 22.21% of the company stock.
Largest 10 shareholders include FMR LLC (3.44M shares), Vivo Capital, LLC (3.32M shares), PERCEPTIVE ADVISORS LLC (2.59M shares), ORBIMED ADVISORS LLC (2.04M shares), RA CAPITAL MANAGEMENT, L.P. (1.96M shares), 5AM Venture Management, LLC (1.86M shares), EVENTIDE ASSET MANAGEMENT, LLC (947K shares), BlackRock Inc. (722K shares), VANGUARD GROUP INC (508K shares), and JANUS HENDERSON GROUP PLC (492K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.